Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (519)
  • Open Access

    RESIDENT’S CORNER

    Phimosis – a diagnostic dilemma?

    Thomas B. McGregor1, John G. Pike2, Michael P. Leonard2

    Canadian Journal of Urology, Vol.12, No.2, pp. 2598-2602, 2005

    Abstract Introduction: Phimosis is defined as the inability to retract the foreskin. Differentiating between physiological phimosis and pathological phimosis is important, as the former is managed conservatively and the latter requires surgical intervention. Referrals of patients with physiological phimosis to urology clinics may create anxiety regarding the need for surgery amongst patients and parents, while unnecessarily expanding the waiting list for specialty assessment.
    Objectives: To determine the ability of referring physicians to differentiate physiological from pathological phimosis, and to see whether there is any difference in this ability between generalists versus specialists.
    Materials and methods: A retrospective chart review… More >

  • Open Access

    ARTICLE

    Canadian guidelines for the management of benign prostatic hyperplasia

    J. Curtis Nickel1, Sender Herschorn2, Jacques Corcos2, Bryan Donnelly1, Doug Drover2, Mostafa Elhilali1, Larry Goldenberg1, John Grantmyre2, Bruno Laroche2, Richard Norman1, Bruce Piercy1, Karen Psooy2, Gary Steinhoff1, John Trachtenberg1, Fred Saad1, Simon Tanguay1

    Canadian Journal of Urology, Vol.12, No.3, pp. 2677-2683, 2005

    Abstract Objective: To develop the first Canadian guidelines for the management of lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
    Methods: These guidelines, developed under a mandate provided by the Canadian Urological Association (CUA), were a collaborative effort between the CUA guidelines committee and the Canadian Prostate Health Council. BPH guidelines developed by the American Urological Association, the European Association of Urology, the World Health Organization International Consultation on BPH, and similar committees from Germany, Sweden and Australia were reviewed. The committee further reviewed a systematic literature search, updated to May 2004, and systematically derived… More >

  • Open Access

    RESIDENT’S CORNER

    Recurrence of a non-seminomatous germ cell tumor in the seminal vesicle 20 years after initial diagnosis and treatment

    Jean-Baptiste Lattouf, Michael Mc Cormack, Louise Yelle, Rachid Hadjeres, Fred Saad

    Canadian Journal of Urology, Vol.11, No.4, pp. 2350-2351, 2004

    Abstract We present a case of a pathologic stage 1, right sided, non-seminomatous germ cell tumor recurrence in the left seminal vesicle, 20 years after initial diagnosis and treatment. The patient was treated with three salvage cycles of bleomycin, etoposide, and cisplatinum. At 24 months of follow-up after completion of chemotherapy, digital rectal and TRUS examinations revealed complete resolution of the lesion. We believe that this tumor is a late metastasis to the contralateral seminal vesicle. More >

  • Open Access

    CASE REPORT

    Wegener’s granulomatosis of the penis: diagnosis and management

    Robert Adam1, Sydney Katz2, Ken Lee3, Michael Jewett4, Ronald Kodama5

    Canadian Journal of Urology, Vol.11, No.4, pp. 2341-2343, 2004

    Abstract A 24 year old uncircumcised man presented with a 1 month history of a painful, fungating lesion on his glans penis. Following biopsy, and further clinical developments, a diagnosis of Wegener’s Granulomatosis (WG) was made. The penile lesion was treated with surgical debridement, and a penile stump was salvageable. This is only the fourth case of WG initially presenting with a penile lesion to be reported in the literature. More >

  • Open Access

    ARTICLE

    A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy

    D. Robert Siemens, Alvaro Morales, Brenda Johnston, Laurel Emerson

    Canadian Journal of Urology, Vol.10, No.1, pp. 1754-1758, 2003

    Abstract Objectives: To compare the effectiveness of two rapid urine tests fibrinogen / fibrin degradation products FDP (Aura Tek FDP, PerImmune Inc., Rockville, Maryland, USA) and bladder tumor antigen BTA (Bard BTA, Bard Canada Inc., Mississauga, Ontario, Canada) to urinary cytology in establishing the diagnosis of transitional cell carcinoma (TCC) in patients with suspected upper tract malignancy.
    Materials and methods: In a prospective study, urine samples were collected from 29 patients with abnormalities of the upper tracts highly suspicious for malignancy. Sensitivity and specificity of the BTA and FDP tests were determined and compared to those of cytology.… More >

  • Open Access

    CASE REPORT

    Segmental testicular infarction: diagnosis and strategy

    Loïc Sentilhes1, Frederick Dunet1, Denis Thoumas2, Alain Khalaf1, Philippe Grise1, Christian Pfister1

    Canadian Journal of Urology, Vol.9, No.6, pp. 1698-1699, 2002

    Abstract exploration was not performed and a period of watchful waiting with evolution control by ultrasonography was decided. Results: After a 3 month follow-up, the ultrasonography control revealed a total re-vascularization of the vessels and a reduction of the lesion size. Conclusion: The authors suggest that the combination of ultrasonography and MRI, in the management of testicular infarction, may avoid invasive surgery. More >

  • Open Access

    ARTICLE

    MCDK not excluded by virtue of function on renal scan

    P. D. Metcalfe1, J. R. Wright Jr.2, P. A. M. Anderson1

    Canadian Journal of Urology, Vol.9, No.6, pp. 1690-1693, 2002

    Abstract Introduction: The conservative management of multicystic dysplastic kidneys (MCDK) has been very successful, largely due to advances in diagnostic imaging. Classically, MCDK is described as a non-functioning cystic renal mass. However, we noticed that the increasing sensitivity of renal scans is able to demonstrate function in MCDK that previously would not have been detected.
    Methods: We describe eight cases of MCDK with elements of function on renal scan, and their follow up.
    Results and conclusions: One half (4/8) of these children underwent nephrectomy, and histology was consistent with MCDK. The remaining 4/8 were successfully followed to radiographic involution, More >

  • Open Access

    ARTICLE

    COUNTERPOINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male

    Richard W. Casey

    Canadian Journal of Urology, Vol.9, No.6, pp. 1681-1683, 2002

    Abstract The recent interest in the potential applications of new testosterone preparations has stimulated industry and physicians to develop indications for their use. Despite little scientific evidence to support the widespread application of testosterone in aging men, a clinical symptom complex called Partial Androgen Deficiency in the Aging Male (PAD AM) has been described. Many of these symptoms can be successfully treated without testosterone administration. The author suggests that prospective randomized clinical trials are necessary to support the application of testosterone in the PADAM patient and until then physicians take a more balanced approach in this More >

  • Open Access

    POINT-COUNTERPOINT DEBATE

    POINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male

    Jeremy P. W. Heaton

    Canadian Journal of Urology, Vol.9, No.6, pp. 1677-1680, 2002

    Abstract Andropause is a problem that can be identified in some men as distinct from the changes associated with aging or chronic disease. These men have mild hypogonadism and a clinical picture that is well within the scope of urologists to identify and manage. Andropause is neither life threatening nor trivial and there are clinical guidelines published that will help to refine the understanding and definition of this condition. The character of andropause is distinct from profound hypogonadism in its relation to age, the scope and degree of contributing symptoms and the marginal reduction in testosterone.… More >

Displaying 511-520 on page 52 of 519. Per Page